Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carlo Salvarani and Gianluigi Bajocchi.
Carlo Salvarani
Connection Strength
0.960
Gianluigi Bajocchi
  1. Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1215-1222.
    View in: PubMed
    Score: 0.229
  2. Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy. Arthritis Rheumatol. 2021 01; 73(1):48-52.
    View in: PubMed
    Score: 0.229
  3. Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al. Ann Rheum Dis. 2020 Jul 06.
    View in: PubMed
    Score: 0.223
  4. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study. Ann Rheum Dis. 2020 07; 79(7):986-988.
    View in: PubMed
    Score: 0.221
  5. Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center. Clin Med Insights Circ Respir Pulm Med. 2021; 15:11795484211001349.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.